|Bid||2.2500 x 0|
|Ask||2.2600 x 0|
|Day's Range||2.1700 - 2.3100|
|52 Week Range||1.9000 - 13.6700|
|Beta (5Y Monthly)||1.52|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb. 12, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.93|
TORONTO — Some of the most active companies traded Wednesday on the Toronto Stock Exchange:Toronto Stock Exchange (17,925.36, up 67.02 points.)Manulife Financial Corp. (TSX:MFC). Financials. Up 33 cents, or 1.27 per cent, to $26.33 on 12 million shares.Bombardier Inc. (TSX:BBD.B). Industrials. Down three cents, or 2.01 per cent, to $1.46 on 10.9 million shares.Suncor Energy Inc. (TSX:SU). Energy. Up 56 cents, or 1.41 per cent, to $40.32 on 9.8 million shares.Kinross Gold Corp. (TSX:K). Materials. Up 30 cents, or 4.25 per cent, to $7.36 on 5.5 million shares.Aurora Cannabis Inc. (TSX:ACB). Health care. Up eight cents, or 3.67 per cent, to $2.26 on 5.2 million shares.Acerus Pharmaceuticals Corp. (TSX:ASP). Health care. Up two cents, or 50 per cent, to six cents on 4.95 million shares. Companies in the news:Bausch Health Companies Inc. (TSX:BHC). Down $2.30 or 6.2 per cent to $34.93. Bausch Health Companies Inc. reported a loss of nearly US$1.52 billion in its latest quarter as it settled a lawsuit over a stock plunge that hit investors in 2015. The company, which keeps its books in U.S. dollars, says the net loss amounted to US$4.30 per diluted share for the quarter compared with a net loss of US$344 million, or 98 cents per diluted share, in the same quarter a year earlier. On an adjusted basis, Bausch Health reported a profit of US$404 million for the final quarter of 2019, up from adjusted net income of US$368 million in the fourth quarter of 2018. Revenue totalled $2.224 billion for the quarter, up from $2.121 billion in the same quarter a year earlier.Stelco Holdings Inc. (TSX:STLC). Up 56 cents or 5.7 per cent to $10.38. Stelco Holdings Inc. swung to a loss in its fourth quarter after challenging market conditions including an "unprecedented" drop in prices. The Hamilton-based steel producer said Wednesday that it lost $24 million or 27 cents per diluted share for the quarter ended Dec. 31, compared with net income of $110 million or $1.23 per diluted for final quarter of 2018. Revenue totalled $435 million, down from $648 million a year earlier. The company said its average steel selling price for the quarter was down 28 per cent compared with last year and steel shipping volumes were down six per cent. Prices were down about 33 per cent from the peak hit in the third quarter last year, but have started to improve this year, the company said.Nutrien Inc. (TSX:NTR). Up $1 or 1.8 per cent to $55.59. A rebound in global agricultural markets is expected to drive better returns this year after a difficult fourth quarter for fertilizer company Nutrien Ltd., its CEO said Thursday. The last three months of 2019 featured ongoing challenges including geopolitical issues and short-term weather anomalies, said Chuck Magro on a conference call to discuss the Saskatoon-based company's financial results. Magro said the week-long Canadian National Railway Co. strike in November resulted in a $10-million fourth-quarter earnings hit. Demand for crop inputs is expected to rise in Nutrien's key North American markets this spring due to an increase in seeded acreage, improved cash crop margins and farmers wanting to catch up on fertilizer applications, he said.Alimentation Couche-Tard Inc. (TSX:ATD.B). Up 12 cents to $44.10. Alimentation Couche-Tard Inc. is facing a rival bidder for Caltex Australia Ltd. Australia's largest retail fuel and convenience chain says EG Group Ltd. has made a takeover offer for the company. Under the proposal, Caltex shareholders would receive roughly AU$15.62 in cash and a security in Ampol, which will own Caltex's fuel and infrastructure business as well as its international trading and shipping operations. Caltex says EG has also indicated that it is prepared to consider acquiring up to 10 per cent of Ampol for additional cash consideration. Quebec-based Couche-Tard raised its offer for all of Caltex last week to AU$35.25 per share in cash less any dividends declared or paid.This report by The Canadian Press was first published Feb. 19, 2020. The Canadian Press
Aurora stock has seen an epic fall in 2019. Can it rise from its ashes or will it continue to dwell at the bottom? Let’s find out.
/R E P E A T -- High Tide Announces Agreement to Sell KushBar Assets to Halo Labs for $12 Million/
Canopy Growth's new CEO David Klein delivered first quarter results that topped expectations across the board as shares popped 15%.
Aurora Cannabis Inc.'s second quarter earnings were weighed down by a drop in cannabis production and the costs associated with ramping up efforts to roll out cannabis edibles and vapes.The Edmonton-based company revealed Thursday that it incurred a loss in its second quarter and that its net revenue for the three months ended Dec. 31 was $56 million, up from $54.2 million a year earlier but down from roughly $75 million in the prior quarter ended Sept. 30. The company says its net loss for the quarter amounted to $1.3 billion or $1.18 per share, compared with a loss of $239.6 million or 25 cents per share a year earlier. It earned $10.3 million in the first quarter.The loss came as Aurora has faced troubled times. A week ago it announced it was taking $1 billion in writedowns and would lay off 500 employees as part of a restructuring of its spending plans. The company also said its chief executive Terry Booth was retiring and a search was underway for his successor."The past year has been challenging for the broader cannabis industry with issues of retail constraints, evolving consumer demand and provincial distributor inventory management adjustments," said Michael Singer, Aurora's interim chief executive, on a call with analysts."It is important to remind ourselves that the Canadian consumer market is just over a year old and will take time to develop, but we remain extremely bullish on the long-term potential of the Canadian medical and consumer markets as well as established international medical markets."Aurora said it was hampered because it produced 30,691 kilograms of cannabis compared with 41,436 kilograms in the first quarter as it changed its cultivation strategies to accommodate more high-value and high-potency strains.Meanwhile, the cost of production increased to 88 cents a gram in the latest quarter. The company hopes to keep that rate below a dollar for the foreseeable future. Aurora — the maker of brands Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and ROAR Sports — said it faced further struggles as it worked to release vapes, concentrates, gummies, chocolates, mints and cookies in time for Cannabis 2.0, which legalized edibles and vapes in Canada a few weeks ago.Aurora had to invest in consumer education for the 2.0 launch and incurred campaign expenses for its rollout of the Aurora Drift brand, executives said.Those moves combined with revenue declines caused the company to report its adjusted EBITDA loss for the third quarter widened to $80.2 million from $44.7 million a year earlier and a loss of $39.7 million in the first quarter.Aurora expects larger-scale production lines that are on their way and a "more prudent" use of capital to help in the future."I want to stress that we recognize the importance of reducing our cost structure," said Glen Ibbott, Aurora's chief financial officer, on call. "We have taken decisive action to make change immediately."Ibbott was referencing the detailed evaluation of all capital projects underway that the company was undertaking after making its cuts last week. Aurora says the move will result in a restructuring of spending plans related to technology, sales and marketing, travel and entertainment, professional services and non-revenue generating third-party costs.The dramatic changes mean Aurora is now expecting its revenues in the next quarter to be impacted by similar headwinds. The company said it now anticipates that it will experience either modest or no growth.Aurora's stock closed up 4 cents or 2.08 per cent at $1.96 on the Toronto Stock Exchange.This report by The Canadian Press was first published Feb. 13.Companies in this story: (TSX:ACB)Tara Deschamps, The Canadian Press
Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of -200.00% and -10.15%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Aurora’s Toronto-listed stock hit a fresh 52-week low on Wednesday, adding to a nearly 80 per cent decline over the past year.
Net Revenue of $66.6 million , excluding provisions of $10.6 million Net Cannabis Revenue, excluding provisions, of $63.2 million , In Line With Recent Guidance Cash Cost to Produce Per Gram Sold of $0.88 ...
Canada's market today mirrors the patchwork of U.S. states where the drug is legal in the worst possible ways, according to one analyst.